vs

Side-by-side financial comparison of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) and RMR GROUP INC. (RMR). Click either name above to swap in a different company.

RMR GROUP INC. is the larger business by last-quarter revenue ($66.7M vs $44.6M, roughly 1.5× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). RMR GROUP INC. runs the higher net margin — 18.3% vs -90.4%, a 108.7% gap on every dollar of revenue. On growth, RMR GROUP INC. posted the faster year-over-year revenue change (40.8% vs 13.8%).

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

RMR Group Inc. is a U.S.-headquartered alternative asset management firm specializing in real estate and real estate-related investments. It operates across commercial property, residential real estate, and infrastructure segments, serving institutional investors, high-net-worth individuals, and retail clients across key global markets.

PACB vs RMR — Head-to-Head

Bigger by revenue
RMR
RMR
1.5× larger
RMR
$66.7M
$44.6M
PACB
Growing faster (revenue YoY)
RMR
RMR
+26.9% gap
RMR
40.8%
13.8%
PACB
Higher net margin
RMR
RMR
108.7% more per $
RMR
18.3%
-90.4%
PACB

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PACB
PACB
RMR
RMR
Revenue
$44.6M
$66.7M
Net Profit
$-40.4M
$12.2M
Gross Margin
37.1%
Operating Margin
-92.3%
48.1%
Net Margin
-90.4%
18.3%
Revenue YoY
13.8%
40.8%
Net Profit YoY
-1802.7%
91.1%
EPS (diluted)
$-0.11
$0.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PACB
PACB
RMR
RMR
Q4 25
$44.6M
$66.7M
Q3 25
$38.4M
Q2 25
$39.8M
Q1 25
$37.2M
Q4 24
$39.2M
Q3 24
$40.0M
Q2 24
$36.0M
Q1 24
$38.8M
Net Profit
PACB
PACB
RMR
RMR
Q4 25
$-40.4M
$12.2M
Q3 25
$-38.0M
Q2 25
$-41.9M
Q1 25
$-426.1M
Q4 24
$2.4M
Q3 24
$-60.7M
Q2 24
$-173.3M
Q1 24
$-78.2M
Gross Margin
PACB
PACB
RMR
RMR
Q4 25
37.1%
Q3 25
41.4%
Q2 25
36.9%
Q1 25
-3.7%
Q4 24
25.6%
Q3 24
25.0%
Q2 24
16.5%
Q1 24
29.1%
Operating Margin
PACB
PACB
RMR
RMR
Q4 25
-92.3%
48.1%
Q3 25
-101.1%
Q2 25
-112.8%
Q1 25
-1154.5%
Q4 24
-390.1%
Q3 24
-160.3%
Q2 24
-488.3%
Q1 24
-209.6%
Net Margin
PACB
PACB
RMR
RMR
Q4 25
-90.4%
18.3%
Q3 25
-98.9%
Q2 25
-105.4%
Q1 25
-1146.8%
Q4 24
6.0%
Q3 24
-151.9%
Q2 24
-481.3%
Q1 24
-201.4%
EPS (diluted)
PACB
PACB
RMR
RMR
Q4 25
$-0.11
$0.71
Q3 25
$-0.13
Q2 25
$-0.14
Q1 25
$-1.44
Q4 24
$-0.44
Q3 24
$-0.22
Q2 24
$-0.64
Q1 24
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PACB
PACB
RMR
RMR
Cash + ST InvestmentsLiquidity on hand
$279.5M
$49.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$5.3M
$232.7M
Total Assets
$784.1M
$687.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PACB
PACB
RMR
RMR
Q4 25
$279.5M
$49.3M
Q3 25
$298.7M
Q2 25
$314.7M
Q1 25
$343.1M
Q4 24
$389.9M
Q3 24
$471.1M
Q2 24
$509.8M
Q1 24
$561.9M
Stockholders' Equity
PACB
PACB
RMR
RMR
Q4 25
$5.3M
$232.7M
Q3 25
$36.1M
Q2 25
$61.5M
Q1 25
$91.6M
Q4 24
$506.6M
Q3 24
$453.1M
Q2 24
$492.7M
Q1 24
$649.0M
Total Assets
PACB
PACB
RMR
RMR
Q4 25
$784.1M
$687.1M
Q3 25
$803.2M
Q2 25
$825.5M
Q1 25
$860.8M
Q4 24
$1.3B
Q3 24
$1.5B
Q2 24
$1.5B
Q1 24
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PACB
PACB
RMR
RMR
Operating Cash FlowLast quarter
$-19.1M
$10.7M
Free Cash FlowOCF − Capex
$-19.9M
FCF MarginFCF / Revenue
-44.6%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
0.88×
TTM Free Cash FlowTrailing 4 quarters
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PACB
PACB
RMR
RMR
Q4 25
$-19.1M
$10.7M
Q3 25
$-18.7M
Q2 25
$-29.4M
Q1 25
$-44.1M
Q4 24
$-30.6M
Q3 24
$-45.5M
Q2 24
$-54.3M
Q1 24
$-75.7M
Free Cash Flow
PACB
PACB
RMR
RMR
Q4 25
$-19.9M
Q3 25
$-18.8M
Q2 25
$-29.9M
Q1 25
$-45.4M
Q4 24
$-32.3M
Q3 24
$-46.3M
Q2 24
$-55.7M
Q1 24
$-79.6M
FCF Margin
PACB
PACB
RMR
RMR
Q4 25
-44.6%
Q3 25
-48.9%
Q2 25
-75.3%
Q1 25
-122.3%
Q4 24
-82.3%
Q3 24
-115.7%
Q2 24
-154.8%
Q1 24
-205.0%
Capex Intensity
PACB
PACB
RMR
RMR
Q4 25
1.9%
Q3 25
0.2%
Q2 25
1.4%
Q1 25
3.7%
Q4 24
4.1%
Q3 24
2.0%
Q2 24
4.1%
Q1 24
10.0%
Cash Conversion
PACB
PACB
RMR
RMR
Q4 25
0.88×
Q3 25
Q2 25
Q1 25
Q4 24
-12.93×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

RMR
RMR

Management Service Incentive$23.6M35%
Industrial Logistics Properties Trust$15.1M23%
Managed Private Real Estate Capital$11.1M17%
Office Properties Income Trust$5.6M8%
Other Private Entities$5.3M8%
RMR Residential$3.4M5%
Sonesta International Hotels Corporation$2.1M3%
Investment Advisory Management And Administrative Service$1.2M2%

Related Comparisons